Descrizione Clinica
Opportunities
Fusion
Description
Multi-dose sterile solution, lubricant and osmoprotective of the eye surface, moisturizes the epithelial cells by restoring the osmotic balance and protects the tear film by improving the lipid layer. It offers superior comfort and prolonged osmoprotection from dry eye symptoms. Optive Fusion is a lacrimal substitute formulated with the combination of hyaluronic acid and OsmoMax technology, which contains carbossimetilcellulose, a combination that ensures immediate and prolonged relief over time: this formulation offers immediate and prolonged comfort, osmoprotection and epitelization of the eye surface through cell migration. It also contains the purified patented protective complex that immediately after exposure to light (when you put drops) degrades into the natural components of the film of tears (water and sodium chloride) and in this way it is comparable to preparations without preservatives. Optive Fusion then improves and stabilizes the tear film, restores the damaged cell surface, offers immediate and prolonged relief from the symptoms of the dry eye. These drops can be used up to 6 months after opening; can also be used during the application of contact lenses of all types; lubrication technology + osmoprotection decreases the frequency of applications of drops; the pure protective substance does not irritate the eye and behaves as a preparation without preservative substance.
Mode of use
It is recommended to instill 1/2 drops in the lower joint sack of each eye by repeating the administration according to the need during the day.
Composition
Sodium carboxyethylcellulose 0.5%; glycerin 0.9%; levocarnitine; erythrole and purite 0.01% as preservative.
Format
10 ml multidose bottle.
Multi-dose sterile solution, lubricant and osmoprotective of the eye surface, moisturizes the epithelial cells by restoring the osmotic balance and protects the tear film by improving the lipid layer. It offers superior comfort and prolonged osmoprotection from dry eye symptoms. Optive Fusion is a lacrimal substitute formulated with the combination of hyaluronic acid and OsmoMax technology, which contains carbossimetilcellulose, a combination that ensures immediate and prolonged relief over time: this formulation offers immediate and prolonged comfort, osmoprotection and epitelization of the eye surface through cell migration. It also contains the purified patented protective complex that immediately after exposure to light (when you put drops) degrades into the natural components of the film of tears (water and sodium chloride) and in this way it is comparable to preparations without preservatives. Optive Fusion then improves and stabilizes the tear film, restores the damaged cell surface, offers immediate and prolonged relief from the symptoms of the dry eye. These drops can be used up to 6 months after opening; can also be used during the application of contact lenses of all types; lubrication technology + osmoprotection decreases the frequency of applications of drops; the pure protective substance does not irritate the eye and behaves as a preparation without preservative substance.
Mode of use
It is recommended to instill 1/2 drops in the lower joint sack of each eye by repeating the administration according to the need during the day.
Composition
Sodium carboxyethylcellulose 0.5%; glycerin 0.9%; levocarnitine; erythrole and purite 0.01% as preservative.
Format
10 ml multidose bottle.